Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: Studies in normotriglyceridemia and moderate hypertriglyceridemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 12, 1996, Pages 1430-1436

  Föger, Bernhard ^a   Ritsch, Andreas ^a   Doblinger, Alfred ^a   Wessels, Holger ^b   Patsch, Josef R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

cholesteryl ester transfer protein; HDL cholesterol postprandial lipemia; lipoprotein lipase; triglycerides

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CORONARY RISK; ENZYME ACTIVITY; HUMAN; HYPERTRIGLYCERIDEMIA; LOW FAT DIET; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 0030481639     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.12.1430     Document Type: Article

References (48)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
2. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
3. 2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978; 75:4519-4523.
4. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993;34:1255-1274.
5. 3 by hepatic lipase. J Clin Invest. 1984;74:2017-2023.
6. 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 1987;80:341-347.
7. AHA Special Report. Recommendations for treatment of hyperlipidemia in adults: a joint statement of the Nutrition Committee and the Council on Atherosclerosis. Circulation. 1984;69:1065A-1090A.
8. 3 in human plasma. Clin Chem. 1989;35:265-270.
9. Menzel HJ, Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 1986;7:492-495.
10. Patsch JR, Sailer S, Kostner G, Sandhofer F, Holasek A, Braunsteiner H. Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res. 1974;15: 356-366.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
12. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959;234:466-468.
13. 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A. 1983;80:1449-1453.
14. Föger B, Patsch JR. Strategies and methods for the assessment of disturbed postprandial lipid metabolism. Curr Opin Lipidol. 1993; 4:428-433.
15. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91: 448-455.
16. Föger B, Königsrainer A, Palos G, Brandstätter E, Ritsch A, König P, Miesenböck G, Lechleitner M, Margreiter M, Patsch JR. Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. Transplantation. 1994;58:899-904.
17. Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 1986;32:283-286.
18. Ritsch A, Auer B, Föger B, Schwarz S, Patsch JR. Polyclonal-antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein. J Lipid Res. 1993;34:673-679.
19. Bortz J. Lehrbuch der Statistik. Berlin, Germany: Springer; 1985: 261-264.
20. Hays WL. Statistics for the Social Sciences. 2nd ed. New York, NY: Holt Rinehart and Winston; 1973:661-667.
21. Arbuckle J. Analysis of Moment Structures (AOMS): User's Manual. Philadelphia, Pa: Department of Psychology, Temple University; 1991.
22. Joereskog KG, Soerbom D. LISREL-VI User's Guide. Mooresville, Ind: Scientific Software Inc; 1984.
23. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb. 1991;11:797-804.
24. Nestel PJ, Reardon M, Billington T. In vivo transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins in man. Biochim Biophys Acta. 1979;573:403-407.
25. Miesenböck G, Patsch JR. Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Curr Opin Lipidol. 1992;3: 196-201.
26. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XJ, Shelanski SA, Breslow JL, Tall AR. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991;266:10796-10801.
27. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama J, Mabuchi H, Tall AR. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990;323:1234-1238.
28. Whitlock ME, Swenson TL, Ramakrishnan R, Leonard MT, Marcel YL, Milne RW, Tall AR. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest. 1989;84:129-137.
29. Abbey M, Calvert GD. Effects of blocking plasma lipid transfer protein activity in the rabbit. Biochim Biophys Acta. 1989;1003:20-29.
30. Yamashita S, Hui DY, Wetterau JR, Sprecher DL, Harmony JAK, Sakai N, Matsuzawa Y, Tarui S. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism. 1991;40:756-763.
31. Groener JEM, Van Rozen AJ, Erkelens DW. Cholesteryl ester transfer activity: localization and role in distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis. 1984;50: 261-271.
32. Tollefson JH, Liu A, Albers JJ. Regulation of plasma lipid transfer by the high-density lipoproteins. Am J Physiol. 1988; 255:E894-E902.
33. Nakanishi T, Tahara D, Akazawa S, Miyake S, Nagataki S. Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects. Metabolism. 1990; 39:225-230.
34. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, Whitlock ME, Tall AR, Milne RW. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest. 1990;85:10-17.
35. Dullaart RPF, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb. 1994;14: 1581-1585.
36. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the Taq I B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994;14: 336-344.
37. Arai T, Yamashita S, Hirano K, Sakai N, Kotani N, Fujioka S, Nozaki S, Yoshiaki K, Yamane M, Shinohara E, Islam AHMW, Ishigami M, Nakamura T, Kameda-Takemura K, Tokunaga K, Matsuzawa Y. Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb. 1994;14:1129-1136.
38. Dullart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest. 1994;24:188-194.
39. Föger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR. Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism. 1994;43:633-639.
40. Brinton EA, Eisenberg S, Breslow JL. Increased apo A-I and A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991;87:536-544.
41. Karpe F, Tornvall P, Olivecrona T, Steiner G, Carlson LA, Hamsten A. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis. 1993; 98:33-49.
42. Watson TDG, Caslake MJ, Freeman DJ, Griffin BA, Hinnie J, Packard CJ, Shepherd J. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb. 1994;14:302-310.
43. Eisenberg S. Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters. J Lipid Res. 1985;26:487-494.
44. Mowri HO, Patsch JR, Ritsch A, Föger B, Brown S, Patsch W. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin:cholesterol acyltransferase. J Lipid Res. 1994;35:291-300.
45. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88:2059-2066.
46. Tato F, Vega GL, Tall AR, Grundy SM. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterio Thromb Vasc Biol. 1995;15:112-120.
47. Moulin P, Appel GB, Ginsberg HN, Tall AR. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J Lipid Res. 1992;33:1817-1822.
48. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism: studies in transgenic mice. J Clin Invest. 1993;92:1143-1152.